Abstract:Objective: Extension of aortic disease to the aortic arch is common, frequently requiring cervical debranching procedures to maintain patency of supra-aortic branches. Endovascular aortic arch repair is an attractive alternative in the treatment of aortic arch disease for high-risk patients with thoracoabdominal diseases encroaching on the arch. The aim of our study was to report our experience of fenestrated endovascular repair in the aortic arch. Methods: A retrospective review of prospectively collected data involving consecutive patients in a single tertiary center treated with custom-made fenestrated endografts for the aortic arch (Cook Medical, Bloomington, Ind) was undertaken. End points included technical success, perioperative mortality and morbidity, reintervention, and late survival. Results: Between 2011 and 2017, there were 44 patients with a mean age of 67 ± 9 years (27 male [61%]) who were treated with fenestrated endografts for arch aneurysm (n = 11 [25%]), arch penetrating aortic ulcer (n = 6 [14%]), thoracoabdominal aneurysm with arch involvement (n = 11 [25%]), postdissection false lumen aneurysm (n = 13 [29%]), or lusorian artery aneurysm (n = 3 [7%]). The proximal landing zone was at Ishimaru zone 0 in 12 cases (27%), zone 1 in 27 cases (62%), and zone 2 in 5 cases (11%). Nine patients (20%) underwent a unilateral carotid-subclavian bypass, two (5%) a bilateral carotid-subclavian bypass, and four (9%) a subclavian transposition. In total, of the 73 target supra-aortic vessels (average of 1.7 target vessels per patient), 37 were treated with fenestrations and 36 with scallops. The mean operation time, fluoroscopy time, and contrast material volume were 215 ± 152 minutes, 33 ± 23 minutes, and 114 ± 45 mL, respectively. Technical success was 95% (42/44). The median intensive care unit and hospital stays were 3 ± 1 days and 7 ± 6 days, respectively. The 30-day mortality was 9% (4/44; one graft displacement and stroke, one retrograde type A dissection, one access complication and stroke, and one death of unknown cause). Major stroke occurred in three (7%), minor stroke in one (2%), temporary spinal cord ischemia in three (7%), and renal injury in three (7%) patients, whereas three (7%) patients required early reintervention. With mean follow-up of 18 ± 17 months, 10 more patients required secondary interventions, most of which (90%) were planned distal intervention to complete the repair of thoracoabdominal diseases. Overall survival rates were 78% ± 7% and 72% ± 8% at postoperative years 1 and 2, respectively. Conclusions: Fenestrated endograft repair of aortic arch disease is a feasible technique with a high technical success rate and acceptable rates of stroke and paraplegia. A high number of secondary interventions were needed to complete the treatment of underlying diseases.

TAA13. Treatment of Aortic Arch Diseases With Three Fenestrated Stent Grafts of In Situ Fenestration and Prefenestration

Three-Dimensional Printing to Guide the Application of Modified Prefenestrated Stent Grafts to Treat Aortic Arch Disease

[Progress on in Situ Fenestration During Thoracic Endovascular Aortic Repair].

A Single Center Experience of in Situ Needle Fenestration of Supra-Aortic Branches During Thoracic Endovascular Aortic Repair.

Three-dimensional printing technique to guide the application of customized fenestrated stent grafts in aortic arch disease

In situ fenestration to preserve supra-aortic branch during thoracic endovascular aortic repair

Technical Details of Thoracic Endovascular Aortic Repair with Fenestrations for Thoracic Aortic Pathologies Involving the Aortic Arch: A Chinese Expert Consensus

Endovascular Repair Combined with Fenestrated Stent Grafts in Treating Aortic Arch Lesions

Endovascular repair combined with in situ fenestration for new-onset or residual arch dissection in patients underwent aortic replacement

Endovascular Repair Combine with In-situ Fenestration for New-Onset or Residual Arch Dissection in Patients Underwent Aortic Replacement

Short-Term Outcomes of in Situ Fenestration in Total Endovascular Aortic Arch Treatment.

Fenestrated endovascular repair for diseases involving the aortic arch

A Novel Internal and External Bypass Method to Safeguard Cerebral Blood Flow During Aortic Arch Endovascular Repair Requiring Triple In Situ Fenestrations

Fenestrated Stent for Arch Repair for Acute Stanford Type A Aortic Dissection – A Conservative Solution for Complex Condition

In Situ Laser Fenestration Is a Feasible Method for Revascularization of Aortic Arch During Thoracic Endovascular Aortic Repair.

Early Experience With Fenestration Modification of Castor Branched Stent-Graft for Aortic Arch Diseases

Novel Arch Fenestrated Stent Graft for Acute Stanford Type A Aortic Dissection with Open Antegrade Implantation.

Endovascular Treatment for Aortic Arch Pathologies: Chimney, On-the-table Fenestration, and In-Situ Fenestration Techniques.

Endovascular Total Arch Repair Using In Situ Fenestration for Arch Aneurysm and Chronic Type A Dissection

Physician-Modified and In Situ Fenestrated Stent Grafts in Zone 0 for Aortic Arch Pathology After Ascending Aortic Replacement

Reconstruction of triple-branched aortic arch guided by three-dimensional technique and its curative effect analysis